secwatch.observer — SEC 8-K summary
======================================

Issuer:     GOLDENWELL BIOTECH, INC. (GWLL)
CIK:        0001800373
Form:       8-K
Filed at:   2025-08-19T23:59:59+00:00
Accession:  0001477932-25-006051
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Goldenwell Biotech's auditor KCCW resigns; Michael Gillespie & Associates appointed
--------------------------------------------------------------------------------

- KCCW resigned as independent registered public accounting firm on July 24, 2025, with no disagreements on accounting principles.
- KCCW's reports for 2023 and 2024 included a going concern qualification about the company's ability to continue.
- Board appointed Michael Gillespie & Associates as the new auditor on August 14, 2025; it previously served from Nov 2024 to Jan 2025.
- No reportable events or disagreements occurred with either former or new auditor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800373/000147793225006051/0001477932-25-006051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800373/000147793225006051/gdwl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-006051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer